{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:35:54Z","timestamp":1791668154474,"version":"4.3.4"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ctrv.2024.102717","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T13:24:47Z","timestamp":1710336287000},"page":"102717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Bridging gaps in cancer cachexia Care: Current insights and future perspectives"],"prefix":"10.1016","volume":"125","author":[{"given":"Carlotta","family":"Bianchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0135-0224","authenticated-orcid":false,"given":"Paolo","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Caccialanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Fabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2024.102717_b0005","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.2147\/CMAR.S261585","article-title":"Cancer cachexia: definition, staging, and emerging treatments","volume":"12","author":"Ni","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ctrv.2024.102717_b0010","article-title":"Cancer cachexia: pathophysiology and association with cancer-related pain","volume":"3","author":"Law","year":"2022","journal-title":"Front Pain Res (Lausanne)"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102717_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/nu13061980","article-title":"The Spectrum of malnutrition\/cachexia\/sarcopenia in oncology according to different cancer types and settings: a narrative review","volume":"13","author":"Bossi","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102717_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100092","article-title":"Cancer cachexia in adult patients: ESMO clinical practice guidelines(\u2606)","volume":"6","author":"Arends","year":"2021","journal-title":"ESMO Open"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102717_b0025","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hed.24672","article-title":"Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma","volume":"39","author":"Kwon","year":"2017","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0035","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00535-013-0787-0","article-title":"Cancer cachexia\u2013pathophysiology and management","volume":"48","author":"Suzuki","year":"2013","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0884533616680354","article-title":"Differentiating sarcopenia and cachexia among patients with cancer","volume":"32","author":"Peterson","year":"2017","journal-title":"Nutr Clin Pract"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","article-title":"Cachexia as a major underestimated and unmet medical need: facts and numbers","volume":"1","author":"von Haehling","year":"2010","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ctrv.2024.102717_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.910770","article-title":"Malnutrition management in oncology: an expert view on controversial issues and future perspectives","volume":"12","author":"Bossi","year":"2022","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102717_b0060","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.nut.2016.02.005","article-title":"Awareness and consideration of malnutrition among oncologists: insights from an exploratory survey","volume":"32","author":"Caccialanza","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.ctrv.2024.102717_b0065","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919899852","article-title":"Unmet needs in clinical nutrition in oncology: a multinational analysis of real-world evidence","volume":"12","author":"Caccialanza","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.ctrv.2024.102717_b0070","doi-asserted-by":"crossref","first-page":"7462940","DOI":"10.1155\/2019\/7462940","article-title":"Inadequate nutrition coverage in outpatient cancer centers: results of a National Survey","volume":"2019","author":"Trujillo","year":"2019","journal-title":"J Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2020.100554","article-title":"Cancer-related malnutrition management: a survey among italian oncology units and patients' associations","volume":"44","author":"Caccialanza","year":"2020","journal-title":"Curr Probl Cancer"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102717_b0080","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.7150\/jca.73130","article-title":"Nutritional support in cancer patients: update of the italian intersociety working group practical recommendations","volume":"13","author":"Caccialanza","year":"2022","journal-title":"J Cancer"},{"issue":"21","key":"10.1016\/j.ctrv.2024.102717_b0085","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of Cancer Cachexia: ASCO guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.ctrv.2024.102717_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/nu15143172","article-title":"Are guideline recommendations on supportive nutrition and exercise therapy for cancer patients implemented in clinical routine? a National Survey with real-life data","volume":"15","author":"Hardt","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","article-title":"ESPEN guidelines on definitions and terminology of clinical nutrition","volume":"36","author":"Cederholm","year":"2017","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102717_b0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clnu.2009.11.010","article-title":"Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the international consensus guideline committee","volume":"29","author":"Jensen","year":"2010","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","article-title":"GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community","volume":"38","author":"Cederholm","year":"2019","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0110","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"19","key":"10.1016\/j.ctrv.2024.102717_b0115","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-13-1066","article-title":"Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system","volume":"19","author":"Laird","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102717_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103965","article-title":"Overcoming barriers to timely recognition and treatment of cancer cachexia: sharing Progress in cancer care task force position paper and call to action","volume":"185","author":"Arends","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102717_b0125","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jcsm.13073","article-title":"Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies","volume":"14","author":"Martin","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.trecan.2022.01.004","article-title":"Emerging signaling mediators in the anorexia-cachexia syndrome of cancer","volume":"8","author":"Talbert","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ctrv.2024.102717_b0135","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.ctrv.2024.102717_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15123206","article-title":"The impact of NUTRItional status at first medical oncology visit on clinical outcomes: the NUTRIONCO study","volume":"15","author":"Muscaritoli","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"45","key":"10.1016\/j.ctrv.2024.102717_b0145","doi-asserted-by":"crossref","first-page":"79884","DOI":"10.18632\/oncotarget.20168","article-title":"Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study","volume":"8","author":"Muscaritoli","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clnu.2013.04.008","article-title":"Nutrition screening tools: does one size fit all? a systematic review of screening tools for the hospital setting","volume":"33","author":"van Bokhorst-de van der Schueren","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ctrv.2024.102717_b0155","doi-asserted-by":"crossref","first-page":"1174945","DOI":"10.3389\/fnut.2023.1174945","article-title":"Prevalence of malnutrition based on global leadership initiative in malnutrition criteria for completeness of diagnosis and future risk of malnutrition based on current malnutrition diagnosis: systematic review and meta-analysis","volume":"10","author":"Bian","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.ctrv.2024.102717_b0160","article-title":"Evaluation of a multidisciplinary cachexia and nutrition support service- the patient and carers perspective","volume":"8","author":"Vaughan","year":"2021","journal-title":"J Patient Exp"},{"key":"10.1016\/j.ctrv.2024.102717_b0165","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.clnesp.2021.04.012","article-title":"Different GLIM criteria combinations change prevalence of malnutrition in patients with intestinal insufficiency or intestinal failure","volume":"44","author":"Mikkelsen","year":"2021","journal-title":"Clin Nutr ESPEN"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0170","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.clnu.2022.03.024","article-title":"Comparison of the prevalence of 21 GLIM phenotypic and etiologic criteria combinations and association with 30-day outcomes in people with cancer: a retrospective observational study","volume":"41","author":"Kiss","year":"2022","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102717_b0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13539-011-0027-5","article-title":"The cachexia score (CASCO): a new tool for staging cachectic cancer patients","volume":"2","author":"Argiles","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ctrv.2024.102717_b0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fphys.2017.00092","article-title":"Validation of the CAchexia SCOre (CASCO). staging cancer patients: the use of miniCASCO as a simplified tool","volume":"8","author":"Argiles","year":"2017","journal-title":"Front Physiol"},{"issue":"8","key":"10.1016\/j.ctrv.2024.102717_b0185","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/annonc\/mdu086","article-title":"Validation of the consensus-definition for cancer cachexia and evaluation of a classification model\u2013a study based on data from an international multicentre project (EPCRC-CSA)","volume":"25","author":"Blum","year":"2014","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102717_b0190","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/jcsm.12275","article-title":"Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients","volume":"9","author":"Zhou","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102717_b0195","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41416-022-01826-2","article-title":"Cancer cachexia: a nutritional or a systemic inflammatory syndrome?","volume":"127","author":"McGovern","year":"2022","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0200","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00520-022-07540-2","article-title":"Development and validation of an online dynamic nomogram system for predicting cancer cachexia among inpatients: a real-world cohort study in China","volume":"31","author":"Huo","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctrv.2024.102717_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2023.112114","article-title":"Development and application of the cancer cachexia staging index for the diagnosis and staging of cancer cachexia","volume":"114","author":"Wang","year":"2023","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102717_b0210","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2214\/AJR.22.27749","article-title":"CT-derived body composition assessment as a prognostic tool in oncologic patients: from opportunistic research to artificial intelligence-based clinical implementation","volume":"219","author":"Bates","year":"2022","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"10.1016\/j.ctrv.2024.102717_b0215","doi-asserted-by":"crossref","first-page":"e2328280","DOI":"10.1001\/jamanetworkopen.2023.28280","article-title":"Development and validation of an automated image-based deep learning platform for sarcopenia assessment in head and neck cancer","volume":"6","author":"Ye","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0220","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/ajcn\/nqac251","article-title":"Identifying cancer cachexia in patients without weight loss information: machine learning approaches to address a real-world challenge","volume":"116","author":"Yin","year":"2022","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0225","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12885-023-11009-8","article-title":"S100A8, S100A9 and S100A8\/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia","volume":"23","author":"Liao","year":"2023","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102717_b0230","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jcsm.13189","article-title":"C-terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review","volume":"14","author":"Monti","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102717_b0235","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/rco2.68","article-title":"Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer-induced cachexia","volume":"5","author":"Chakedis","year":"2022","journal-title":"JCSM Rapid Commun"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102717_b0240","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jcsm.12168","article-title":"Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia","volume":"8","author":"Narasimhan","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0245","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcsm.12201","article-title":"A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer","volume":"8","author":"Solheim","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jcsm.12351","article-title":"Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer","volume":"10","author":"Naito","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102717_b0255","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/advances\/nmaa111","article-title":"A critical review of multimodal interventions for cachexia","volume":"12","author":"McKeaveney","year":"2021","journal-title":"Adv Nutr"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102717_b0260","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkad035","article-title":"Nutrition as prevention for improved cancer health outcomes: a systematic literature review","volume":"7","author":"Parsons","year":"2023","journal-title":"JNCI Cancer Spectr"},{"issue":"8","key":"10.1016\/j.ctrv.2024.102717_b0265","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/jnci\/djad079","article-title":"The pathways to prevention program: nutrition as prevention for improved cancer outcomes","volume":"115","author":"Hiatt","year":"2023","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0270","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2017.10.015","article-title":"Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy","volume":"126","author":"Cereda","year":"2018","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0275","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.clnu.2013.06.012","article-title":"Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review","volume":"32","author":"Langius","year":"2013","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102717_b0280","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00520-009-0686-3","article-title":"Nutritional support for head and neck cancer patients receiving radiotherapy: a systematic review","volume":"18","author":"Garg","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctrv.2024.102717_b0285","doi-asserted-by":"crossref","unstructured":"de Aguiar Pastore Silva J, Emilia de Souza Fabre M, Waitzberg DL. Omega-3 supplements for patients in chemotherapy and\/or radiotherapy: A systematic review. Clin Nutr. 2015;34(3):359\u2013366.","DOI":"10.1016\/j.clnu.2014.11.005"},{"key":"10.1016\/j.ctrv.2024.102717_b0290","doi-asserted-by":"crossref","unstructured":"van der Meij BS, van Bokhorst-de van der Schueren MA, Langius JA, Brouwer IA, van Leeuwen PA. n-3 PUFAs in cancer, surgery, and critical care: a systematic review on clinical effects, incorporation, and washout of oral or enteral compared with parenteral supplementation. Am J Clin Nutr. 2011;94(5):1248\u20131265.","DOI":"10.3945\/ajcn.110.007377"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102717_b0295","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00520-019-04999-4","article-title":"A systematic review examining nutrition support interventions in patients with incurable cancer","volume":"28","author":"Blackwood","year":"2020","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102717_b0300","article-title":"Exercise for cancer cachexia in adults","volume":"3","author":"Grande","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0305","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1186\/s12885-019-5896-6","article-title":"Short- and long-term impact of adapted physical activity and diet counseling during adjuvant breast cancer therapy: the \u201cAPAD1\u201d randomized controlled trial","volume":"19","author":"Carayol","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0310","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1186\/s12885-019-6310-0","article-title":"A single exercise session improves side-effects of chemotherapy in women with breast cancer: an observational study","volume":"19","author":"Johnsson","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctrv.2024.102717_b0315","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.00871","article-title":"Randomized trial of exercise and nutrition on chemotherapy completion and pathologic complete response in women with breast cancer: the lifestyle, exercise, and nutrition early after diagnosis study","author":"Sanft","year":"2023","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102717_b0320","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/jamaoto.2022.2313","article-title":"Adhering to eat and exercise status during radiotherapy for oropharyngeal cancer for prevention and mitigation of radiotherapy-associated dysphagia","volume":"148","author":"Barbon","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"25","key":"10.1016\/j.ctrv.2024.102717_b0325","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1200\/JCO.23.01280","volume":"41","author":"Roeland","year":"2023","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.ctrv.2024.102717_b0330","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.22.01997","article-title":"Randomized double-blind placebo-controlled study of olanzapine for chemotherapy-related anorexia in patients with locally advanced or metastatic gastric, hepatopancreaticobiliary, and lung cancer","volume":"41","author":"Sandhya","year":"2023","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102717_b0335","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jamaoncol.2020.1052","article-title":"Olanzapine for the treatment of advanced cancer-related chronic nausea and\/or vomiting: a randomized pilot trial","volume":"6","author":"Navari","year":"2020","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.ctrv.2024.102717_b0340","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00520-009-0739-7","article-title":"Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial","volume":"18","author":"Navari","year":"2010","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0345","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcsm.12675","article-title":"The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers","volume":"12","author":"Wakabayashi","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ctrv.2024.102717_b0350","doi-asserted-by":"crossref","first-page":"e389942","DOI":"10.1200\/EDBK_389942","article-title":"Current therapeutic targets in cancer cachexia: a pathophysiologic approach","volume":"43","author":"Kadakia","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ctrv.2024.102717_b0355","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2023.5232","article-title":"Mirtazapine as appetite stimulant in patients with non-small cell lung cancer and anorexia: a randomized clinical trial","author":"Arrieta","year":"2024","journal-title":"JAMA Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.ctrv.2024.102717_b0360","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.21037\/tau.2019.11.02","article-title":"Selective androgen receptor modulators: the future of androgen therapy?","volume":"9","author":"Christiansen","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102717_b0365","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","article-title":"The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial","volume":"2","author":"Dalton","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102717_b0370","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2024.102717_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.836804","article-title":"Exercise in people with cancer: a spotlight on energy regulation and cachexia","volume":"13","author":"Allan","year":"2022","journal-title":"Front Physiol"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102717_b0380","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0385","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/14656566.2023.2194489","article-title":"Current advancements in pharmacotherapy for cancer cachexia","volume":"24","author":"da Fonseca","year":"2023","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102717_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103689","article-title":"Update on the treatment of cancer cachexia","volume":"28","author":"Nishie","year":"2023","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102717_b0395","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/er.2009-0037","article-title":"The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology","volume":"31","author":"Tao","year":"2010","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102717_b0400","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jcsm.13191","article-title":"Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia","volume":"14","author":"Herodes","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102717_b0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24031849","article-title":"Targeting gut microbiota in cancer cachexia: towards new treatment options","volume":"24","author":"Panebianco","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0410","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: clinical nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0415","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1016\/j.clnu.2021.03.010","article-title":"Nutrition education in medical schools (NEMS) project: joining ESPEN and university point of view","volume":"40","author":"Cuerda","year":"2021","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0420","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s00520-020-05736-y","article-title":"The provision of nutritional advice and care for cancer patients: a UK national survey of healthcare professionals","volume":"29","author":"Murphy","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctrv.2024.102717_b0425","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.00126","article-title":"Impact of BMI in patients with early hormone receptor-positive breast cancer receiving endocrine therapy with or without palbociclib in the PALLAS trial","author":"Pfeiler","year":"2023","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102717_b0430","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00520-006-0212-9","article-title":"Critical weight loss in head and neck cancer\u2013prevalence and risk factors at diagnosis: an explorative study","volume":"15","author":"Jager-Wittenaar","year":"2007","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102717_b0435","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.ctrv.2024.102717_b0440","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.oraloncology.2016.09.006","article-title":"Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients","volume":"62","author":"Swartz","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctrv.2024.102717_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2024.01.205","article-title":"Five-year mortality outcomes for eating as treatment (EAT), a health behaviour change intervention to improve nutrition in patients with head and neck cancer: a stepped-wedge, randomised controlled trial","author":"Britton","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102717_b0450","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1007\/s00520-017-3826-1","article-title":"Nutritional support for cancer patients: still a neglected right?","volume":"25","author":"Caccialanza","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctrv.2024.102717_b0455","unstructured":"Salute Md. Accordo Stato-Regioni su \u201cLinee di indirizzo sui percorsi nutrizionali nei pazienti oncologici\u201d(rep. atti n. 224\/csr; 14\/12\/2017) 2017 [Available from: https:\/\/www.salute.gov.it\/portale\/documentazione\/p6_2_{21.jsp?lingua=italiano&id=2682."},{"key":"10.1016\/j.ctrv.2024.102717_b0460","article-title":"Is virtual nutritional counseling efficacious for cancer patients during the COVID-19 pandemic?","author":"Bas","year":"2023","journal-title":"J Telemed Telecare"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102717_b0465","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1007\/s00520-020-05557-z","article-title":"Providing nutritional care to cancer patients during the COVID-19 pandemic: an italian perspective","volume":"28","author":"Lobascio","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctrv.2024.102717_b0470","doi-asserted-by":"crossref","first-page":"1134793","DOI":"10.3389\/fnut.2023.1134793","article-title":"Web-based nutrition: a useful resource for cancer patients?","volume":"10","author":"Lazar","year":"2023","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102717_b0475","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.2196\/mhealth.7702","article-title":"Comparing diet and exercise monitoring using smartphone app and paper diary: a two-phase intervention study","volume":"6","author":"Jimoh","year":"2018","journal-title":"JMIR Mhealth Uhealth"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102717_b0480","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211045507","article-title":"Narrative medicine: feasibility of a digital narrative diary application in oncology","volume":"50","author":"Cercato","year":"2022","journal-title":"J Int Med Res"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737224000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737224000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T04:12:31Z","timestamp":1713931951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737224000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":96,"alternative-id":["S0305737224000446"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2024.102717","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging gaps in cancer cachexia Care: Current insights and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2024.102717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102717"}}